-
Teva names two new executives
JERUSALEM — Teva Pharmaceutical Industries has named Carlo De Notaristefani as president and CEO of global operations and Aharon "Arik" Yaari as EVP community and institutional affairs, the Israeli drug maker said Thursday.
The company said De Notaristefani and Yaari would report directly to Teva president and CEO Jeremy Levin.